Terapia de activación conductual en pacientes con cáncer

  1. Fernández Rodríguez, Concepción 1
  2. Villoria Fernández, Erica 1
  3. Amigo Vázquez, Isaac 1
  1. 1 Universidad de Oviedo
    info

    Universidad de Oviedo

    Oviedo, España

    ROR https://ror.org/006gksa02

Revista:
Anales de psicología

ISSN: 0212-9728,  1695-2294

Año de publicación: 2011

Volumen: 27

Número: 2

Páginas: 278-291

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openDIGITUM editor

Otras publicaciones en: Anales de psicología

Resumen

Objetivo: Valorar la eficacia de la Terapia de Activación Con-ductual con pacientes con cáncer de pulmón y cáncer de mama durante el tratamiento oncológico. Procedimiento: Se establecen como criterio de resultado: frecuencia e intensidad de síntomas de enfermedad y/o trata-miento; afectación de la autonomía personal, actividad doméstica, laboral, ocio, relaciones familiares y sociales y alteraciones emocionales. Los datos se recogen mediante escalas estandarizadas (IK, HAD, QLQ-C30), autoin-forme y entrevista clínica en cada sesión de tratamiento y en un seguimien-to de tres meses. Se empleó un grupo control que ocupó el mismo número de sesiones en la evaluación de la calidad de vida. El total de participantes con cáncer de mama fueron 54 (G.C.: N = 29 / G.E.: N = 25) y con cáncer de pulmón 84 (G.C.: N = 37 / G.E.: N = 47). Resultados: Los análisis de comparación inter e intra grupos indican que entre los pacientes con cáncer de pulmón, el G.E. presenta significativamente menos pérdida de apetito, dificultades para dormir, ansiedad, depresión y mayor recupera-ción de actividades cotidianas y de ocio. Entre los pacientes con cáncer de mama no hay diferencias entre grupos pero el efecto tiempo resultó signi-ficativo en la evolución negativa del cansancio y la fatiga. Conclusiones: los pacientes que, durante el tratamiento con quimioterapia, mantienen sus actividades cotidianas y de ocio no presentan alteraciones emocionales. La activación conductual puede contribuir a mejorar la calidad de vida y pre-venir alteraciones emocionales

Referencias bibliográficas

  • Aaronson, N.K., Bullinger, M. y Ahmedzai, S. (1988). A modular approach to quality of life assessment in cancer clinical trials. Recent Results in Cancer Research, 111, 231-249.
  • Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J. Filiberti, A., Flechtner, H., Fleishman, S.B., de Haes J.C., Kaasa, S., Klee, M., Osoba, D., Razavi, D., Rofe, P.B., Schraub, S., Sneeuw, K., Sullivan, M. y Takeda, F. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-376.
  • Arrarás, J.I., Illarramendi, J.L. y Valerdi, J. (1995). El Cuestionario de Calidad de Vida para cáncer de la EORTC, QLQ-C30. Estudio estadístico de validación con una muestra española Revista Española de Psicología de la Salud, 7, 13-33.
  • Brintzenhofe-Szoc, K.M., Levin, T.T., Li, Y., Kissane, D.W. y Zabora, J.R. (2009). Mixed/depression symptoms in a large. cancer cohort: prevalence by cancer type. Psycosomatics, 50, 383-91.
  • Burgess, C., Cornelius, V., Love, S., Graham, J., Richards, M. y Ramírez, A. (2005). Depression and anxiety in women with early breast cancer: five year observational cohort study. British Medical Journal, 330, 702/ bmj.38343.670868. D3. 19/11/09.
  • Cappiello, M., Cunningham, R.S., Knobf, M.T. y Erdos D. (2007). Breast cancer survivors: information and support after treatment. Clinical Nursing Research,16, 278-293.
  • Coates, A., Hurny, C., Peterson, H.F., Bernhard, J., Castiglione-Gertsch, M., Gelber, R.D. y Goldhirsch, A. (2000). Quality of life scores predict out-come in metastatic but not early breast cancer. International Breast Cancer Study Group. Journal of Clinical Oncology, 18, 3768-3774.
  • Cody, M. (1994). Depression and the use of antidepressants in patients with cancer. Palliative Medicine, 4, 271-278.
  • Croyle, R.T. y Rowland, J.H. (2003). Mood disorders and cancer: A National Cancer Institute perspective. Biological Psychiatry, 54, 191-194.
  • Deshields, T., Tibbs, T., Fan, M.Y. y Taylor, M. (2006). Differences in patterns of depression after treatment for breast cancer. Psychooncology, 15, 398-406.
  • Efficace, F., Biganzoli, L., Piccart, M. J., Coens, C., Van Steen, K., Cufer, T., Coleman, R.E., Calvert, H.A., Gamucci, T., Twelves, C., Fargeot, P. y Bottomley, A. (2004). Baseline health-related quality of life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. European Journal of Cancer, 40, 1021-1030.
  • Ciaramella, A. y Poli, P. (2001). Assessment of depression among cancer patients: the role of pain, cancer type and treatment. Psychooncology, 10, 156-165.
  • Dow, K.H. y Lafferty, P. (2000). Quality of life, survivorship, and psychosocial adjustment of young women with breast cancer after breast-conserving surgery and radiation therapy. Oncology Nursing Forum, 27, 1555-1564.
  • Espantoso, R., Fernández, C., Padierna, C., Amigo, I., Villoria, E., Gracia, J.M., Fernández, R., Peláez, I. (2007). Calidad de vida en pacientes oncológicos un año después de finalizado el tratamiento. Psicooncología, 4, 43-57.
  • Faller, H., Schmidt, M. (2004). Prognostic value of depressive coping and depression in survival of lung cancer patients. Psychooncology, 13, 359-363.
  • Fernández, C., Padierna, C., Amigo, I., Gracia, J. M., Fernández, R., y Pel-áez, I. (2006). Calidad de vida informada en pacientes oncológicos paliativos. Index de Enfermería, 52-53, 30-34.
  • Fischer, D.J., Villines, D., Kim, Y.O., Epstein, J.B. y Wilkie, D.J. (2009). Anxiety, depression, and pain: differences by primary cancer. Supportive Care in Cancer, 17. http://resources.metapress.com/pdf-preview.axd?code=du7r5178q544h332&size=largest, 19/11/09.
  • Foster, C., Wright, D., Hill, H., Hopkinson, J. y Roffe, L. (2009). Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. European Journal of Cancer Care, 18, 223-247.
  • Ganz, P.A., Coscarelli, A., Fred, C., Kahn, B., Polinsky, M.L. y Petersen. L. (1996). Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Research and Treatment, 38,183-199.
  • Gilbert, F.J., Cordiner, C.M., Affleck, I.R., Hood, D.B., Mathieson, y Walker, L.G. (1998). Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer. European Journal of Cancer, 34, 2010-2014.
  • Goodwin, J.S., Zhang, D.D. y Ostir, G.V. (2004). Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. Journal of the American Geriatrics Society, 52, 106-111.
  • Groenvold, M., Petersen, M.A., Idler, E., Bjorner, J.B., Fayers, P.M. y Mouridsen, H.T. (2007). Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Research and Treatments, 105, 209-219.
  • Hjerl, K., Andersen, E.W., Keiding, N., Mouridsen, H.T., Mortensen, P.B. y Jorgensen, T. (2003). Depression as a prognostic factor for breast cancer mortality. Psychosomatics,44, 24-30.
  • Hoey, L., Ieropoli, S., White, V. y Jefford, L. (2008). Systematic review of peer support programs for people with cancer. Patient Education and Counselling, 70, 315-337.
  • Holzner, B., Kemmler, G., Cella, D., De Paoli, C., Meraner, V., Kopp, M., Greil, R., Fleischhacker, WW. y Sperner-Unterweger B. (2004). Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncologica, 43, 53-60.
  • Hopko, D. R., Bell, J.L., Armento, M. E. A., Hunt, M.K. y Lejuez, C. W. (2005). Behavior therapy for depressed cancer patients in primary care. Psychotherapy: Theory, Research, Practice and Training, 42, 236-243.
  • Hopko, D.R., Bell, J.L., Armento, M., Robertson, S., Mullane, C., Wolf, N. y Lejuez, C.W. (2008). Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behavior Therapy, 39, 126-136.
  • Jacobson, N. S. (1997). Can contextualism help? Behavior Therapy, 28, 435-443.
  • Jacobson, N. S., Martell, C. R. y Dimigjian, S. (2001). Behavioural activation treatment for depression: returning to contextual roots. Clinical Psychology: Science and Practice, 8, 255-270.
  • Karnofsky, D.A., Abelman, W.H., Craver, L.F. y Burchenal, J.H. (1948). The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer, 1, 634-656.
  • Kramer, J.A., Curran, D., Piccart, M., de Haes, J.C., Bruning, P., Klijn, J., Van Hoorebeeck, I. y Paridaens, R. (2000). Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. European Journal of Cancer, 36, 1498-1506.
  • Lejuez, C. W., Hopko, D. R. y Hopko, S. D. (2001). A brief behavioral activation treatment for depression. Treatment manual. Behavior Modification, 25, 255-286.
  • Lewinsohn, P.M., Muñoz, R.F., Youngren, M.A. y Zeis, A.M. (1978). Control your depression. Englewood Cliffs, NJ: Prentice-Hall.
  • Luoma, M.L., Hakamies-blomqvist, L., Sjostrom, J., Pluzanska, A., Ottoson, S,. Mouridsen, H., Bengtsson, N.O., Bergh, J., Malmström, P., Valvere, V., Tennvall, L. y Blomqvist, C. (2003). Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. European Journal of Cancer, 39, 1370-1376.
  • Mols, F., Vingerhoets, A. J., Coebergh, J.W. y van de Poll-Franse, L.V. (2005). Quality of life among long-term breast cancer survivors: a systematic review. European Journal of Cancer, 41, 2613-26139.
  • Mor, V., Laliberte, L. y Morris, J.N. (1984). The Karnofsky performance status scale: an examination of its reliability an validity in a research setting. Cancer, 52, 2002-2007.
  • Osborne, R.H., Elsworth, G.R., Sprangers, M.A., Oort, F.J., Hopper, J.L. (2004). The value of the Hospital Anxiety and Depression Scale (HADS) for comparing women with early onset breast cancer with population-based reference women. Quality of Life Research, 13, 191, 206.
  • Padierna, C., Fernández, C., Amigo, I., Gracia, J. M., Fernández, R., Peláez, I., y Pérez, M. (2004). Estudio longitudinal de los parámetros de calidad de vida en pacientes oncológicos. Psicooncología, 1, 191-204.
  • Payne, D.K., Hoffman, R.G., Theodoulou, M., Dosik, M. y Massie, M.J. (1999). Screening for anxiety and depression in women with breast cancer. Psychiatry and Medical Oncology gear up for managed care. Psychosomatics, 40(1), 64-69.
  • Salzer, M.S., Palmer, S.C., Kaplan, K., Brusilovskiy, E., Ten Have, T., Hampshire, M., Metz, J. y Coyne, J.C. (2009). A randomized, controlled study of Internet peer-to-peer interactions among women newly diagnosed with breast cancer. Psychooncology, 29. www.ncbi.nlm.nih.gov/pubmed/19484712. 30/10/09.
  • Sandoval, G.A., Brown, A.D., Sullivan, T. y Green, E. (2006). Factors that influence patient's overall perceptions of quality of care. International Journal of Quality Health Care, 18, 266, 274.
  • Sammarco, A. (2001). Perceived social support, uncertainty, and quality of life of younger breast cancer survivors. Cancer Nursing, 24, 212-219.
  • Sammarco, A. y Konecny, L.M. (2008). Quality of life, social support, and uncertainty among Latina breast cancer survivors. Oncology Nursing Forum, 35, 844-949.
  • Sarna, L., Brown, J.K., Cooley, M.E., Williams, R.D., Chernecky, C., Padilla, G. y Danao. L.L. (2005). Quality of life and meaning of illness of women with lung cancer. Oncology Nursing Forum, 19, 9-19.
  • Schou, I., Ekeberg, Ø. y Ruland, CM. (2005). The mediating role of appraisal and coping in the relationship between optimism-pessimism and quality of life. Psychooncology, 14, 718-727.
  • Sorensen, J.B., Klee, M., Palshof, T. y Hansen, H.H. (1993). Performance status assessment in cancer patients. An inter-observer variability study. British Journal of Cancer, 67, 773-775.
  • Stiegelis, H.E., Ranchor, A.V. y Sanderman, R. (2004). Psychological functioning in cancer patients treated with radiotherapy. Patient Education and Counselling, 52, 131-141.
  • Terol, M.C., López-Roig, S., Rodríguez-Marín, J., Pastor, M.A., Mora, M., Martín-Aragón, M. (2000). Diferencias en la calidad de vida: un estudio longitudinal de pacientes de cáncer recibiendo tratamientos de quimioterapia. Anales de Psicología, 16, 111-122.
  • Teunissen, S, de Graeff, A., Voest, E.E. y de Haes, J.C. (2007). Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliative Medicine, 21, 341-346.
  • Yang, B.K., Crisci, A., Young, M.D., Silverstein, A.D., Peterson, B.L. y Dahm, P. (2005). Cross-sectional survey of long-term quality of life after radical perineal prostatectomy. Urology, 65,120-125
  • Zigmond, A.S. y Snaith, R.P. (1983). The Hospital Anxiety and Depression scale. Acta Psychiatrica Scandinava, 67, 361-368.
Fuente de los datos: Dialnet